Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousInformation on the Public Patent Advisory Committee
By Dennis Crouch, Esq.
The USPTO's Patent Public Advisory Committee (PPAC) is charged with reviewing the 'policies, goals, performance, budget, and fees' of the USPTO. The PPAC tends to work closely with USPTO upper management, including the director. PPAC members are public officials and are also paid by the government for their services at a rate well above my salary.
Although the PPAC serves only an advisory role, its members do have a direct-line to the PTO director that is mandated by statute. Folks with particular concerns may do well to contact the members directly. Since the USPTO does not offer contact-information for these officials, so I thought I would do so here.
Current PPAC Members:
- Marc Adler, former Chief IP Counsel at Rohm & Haas, now an independent consultant. [Contact].
- Louis Foreman, product designer, inventor, and author. [Contact].
- F. Scott Kieff, professor at GWU Law School and Senior Fellow at Stanford's Conservative Think Tank, the Hoover Institution. [Contact].
- Damon Matteo, IP director (intellectual capital management) at the Palo Alto Reserach Center (parc). [Contact].
- Steve Pinkos, former Deputy PTO Director, now a lobbyist and IP Advisor. [Contact].
- Maureen Toohey, Patent attorney at her own law firm (Toohey Law Group). [Contact].
Full post as published by Patently Obvious on December 18, 2009 (boomark / email).
Foreign Investment and National Security Act of 2007
Strengthens examination requirements of the Committee on Foreign Investment in the United States
Sex Offender Lists
Registries by State and County
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
California Pistachios
FDA Issues Salmonella Advisory for Certain Brands
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Nursing Home Abuse
New Data Made Public

USPTO NEWS: Patent Public Advisory Committee to Meet Thursday
SEC Advisory Committee on Improvements to Financial Reporting Notices Meeting
SEC's Investor Advisory Committee Announces Public Meeting
Next Meeting of the FCC's Consumer Advisory Committee Scheduled For Sept. 10
SEC Advisory Committee Releases Report on Financial Reporting
USPTO Requests Comments on Enhancement of Patent Quality









